Drug maker tests new version of blockbuster medicine
NCT ID NCT05976386
Summary
This study aimed to see if a new version of the drug dupilumab behaves the same way in the body as the current version. It involved 182 healthy adults who received a single injection of one of the two versions. Researchers then tracked the drug levels in the blood and monitored for side effects over about two months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Pharmacology of Miami-Site Number:8400001
Miami, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.